Maria Castedo

Active 1995–2024

50
Papers
21,954
Citations
46
h-index
50
i10-index

Citations

Citations per year for Maria Castedo1990: 1 citations1995: 7 citations1996: 78 citations1997: 240 citations1998: 446 citations1999: 394 citations2000: 306 citations2001: 229 citations2002: 196 citations2003: 205 citations2004: 189 citations2005: 179 citations2006: 136 citations2007: 174 citations2008: 170 citations2009: 165 citations2010: 185 citations2011: 178 citations2012: 200 citations2013: 241 citations2014: 237 citations2015: 237 citations2016: 214 citations2017: 197 citations2018: 188 citations2019: 623 citations2020: 674 citations2021: 640 citations2022: 451 citations2023: 371 citations2024: 490 citations2025: 226 citations2026: 4 citations1991–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,362 citing papers, 23.2% of this breakdownChina: 1,600 citing papers, 15.7% of this breakdownFrance: 786 citing papers, 7.7% of this breakdownGermany: 476 citing papers, 4.7% of this breakdownUnited Kingdom: 464 citing papers, 4.5% of this breakdownItaly: 457 citing papers, 4.5% of this breakdownJapan: 288 citing papers, 2.8% of this breakdownCanada: 280 citing papers, 2.7% of this breakdownAustralia: 215 citing papers, 2.1% of this breakdownBelgium: 209 citing papers, 2.1% of this breakdownIndia: 208 citing papers, 2% of this breakdownSpain: 199 citing papers, 2% of this breakdown
0%23.2%Other 26%

Fields

  • Biochemistry, Genetics and Molecular Biology44.9%
  • Medicine33.3%
  • Immunology and Microbiology11%
  • Engineering3.6%
  • Neuroscience1.9%
  • Materials Science1.4%
  • Other3.9%

Topics

  • Cell death mechanisms and regulation5.7%
  • Mitochondrial Function and Pathology4%
  • Autophagy in Disease and Therapy3.5%
  • Immunotherapy and Immune Responses3.2%
  • Cancer Immunotherapy and Biomarkers3%
  • Nanoplatforms for cancer theranostics2.3%
  • Other78.3%

Coauthors

All papers

Open in search
  1. Calreticulin exposure dictates the immunogenicity of cancer cell death

    Authors: , , , , , , , , , , , , , , , , - Nature Medicine 2006 cited by 3,103

  2. Molecular mechanisms of cisplatin resistance

    Authors: , , , , , , , - Oncogene 2011 cited by 2,771

  3. Systems biology of cisplatin resistance: past, present and future

    Authors: , , , , , , , - Cell Death and Disease 2014 cited by 779

  4. Mitotic catastrophe: a mechanism for avoiding genomic instability

    Authors: , , , - Nature Reviews Molecular Cell Biology 2011 cited by 809

  5. An Immunosurveillance Mechanism Controls Cancer Cell Ploidy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicole L. Messina, Ming Li, Christopher J. Chan, Verena Sigl, Guillaume Pourcher, Christoph Ruckenstuhl, Didac Carmona‐Gutiérrez, Vladimir Lazar, Josef Penninger, Frank Madeo, Carlos López-Otı́n, Mark J. Smyth, Laurence Zitvogel, Maria Castedo, Guido Kroemer - Science 2012 cited by 427

  6. Cell death modalities: classification and pathophysiological implications

    Authors: , , , , , , - Cell Death and Differentiation 2007 cited by 824

  7. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death.

    Authors: , , , , , , , , , - The Journal of Experimental Medicine 1995 cited by 1,567

  8. Cell death by mitotic catastrophe: a molecular definition

    Authors: , , , , , - Oncogene 2004 cited by 1,241

  9. Autophagic removal of micronuclei

    Authors: , , , , , , , , , , , - Cell Cycle 2012 cited by 195

  10. Metabolic vulnerability of cisplatin‐resistant cancers

    Authors: , , , , , , , , , , , - The EMBO Journal 2018 cited by 129

  11. Effects of acyl-coenzyme A binding protein (ACBP)/diazepam-binding inhibitor (DBI) on body mass index

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Cell Death and Disease 2021 cited by 38

  12. Mitochondrial gateways to cancer

    Authors: , , , , , , , , , - Molecular Aspects of Medicine 2009 cited by 297

  13. The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1

    Authors: , , , , , , , , , , , , , , , - Cell Death and Differentiation 2009 cited by 284

  14. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo.

    Authors: , , , , , , - The Journal of Experimental Medicine 1995 cited by 1,179

  15. Cisplatin Resistance Associated with PARP Hyperactivation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2013 cited by 170

  16. Illicit survival of cancer cells during polyploidization and depolyploidization

    Authors: , , , , , , - Cell Death and Differentiation 2010 cited by 164

  17. Characterization of novel MPS1 inhibitors with preclinical anticancer activity

    Authors: , , , , , , , , , , , , , , , , , - Cell Death and Differentiation 2013 cited by 111

  18. Inhibition of acyl-CoA binding protein (ACBP) by means of a GABAARγ2-derived peptide

    Authors: , , , , , , , , , , , , , , , , , , , - Cell Death and Disease 2024 cited by 12

  19. Mammalian Target of Rapamycin (mTOR): Pro- and Anti-Apoptotic

    Authors: , , - Cell Death and Differentiation 2002 cited by 229

  20. Apoptosis regulation in tetraploid cancer cells

    Authors: , , , , , , , , , , , , , , , , - The EMBO Journal 2006 cited by 202

  21. Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas Robert, Hugues Ripoche, Frédéric Commo, Benjamin Besse, Pierre Validire, Pierre Fouret, Angélique Robin, Nicolas Dorvault, Philippe Girard, Sébastien Gouy, Patricia Pautier, Nora Jägemann, Ann‐Christin Nickel, Sabrina Marsili, Caroline Paccard, Nicolas Servant, Philippe Hupé, Carmen Behrens, Parviz Behnam‐Motlagh, Kimitoshi Kohno, Isabelle Cremer, Diane Damotte, Marco Alifano, Øivind Midttun, Per Magne Ueland, Vladimir Lazar, Philippe Dessen, Hans Zischka, Étienne Chatelut, Maria Castedo, Frank Madeo, Emmanuel Barillot, Jüergen Thomale, Ignacio I. Wistuba, Catherine Sautès‐Fridman, Laurence Zitvogel, Jean‐Charles Soria, Annick Harel‐Bellan, Guido Kroemer - Cell Reports 2012 cited by 134

  22. Functions of BCL-XLat the Interface between Cell Death and Metabolism

    Authors: , , , , , , - International Journal of Cell Biology 2013 cited by 94

  23. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease.

    Authors: , , , , , , , , - The Journal of Experimental Medicine 1996 cited by 1,140

  24. Mitochondrial control of nuclear apoptosis.

    Authors: , , , , , , - The Journal of Experimental Medicine 1996 cited by 1,364